Gilles is one tall tale - he has to go!!!
Proph.... everything you told us here in the past months about the great phantansy in the different areas of Ceapro was a great collection of fairy tale narratives.
Although Gilles highlighted in the annual report that he sees "shareholder value" as one of his key points for 2023, the truth is now on the table.
Shareholders are losing their money and he gets his check ev
ery month.
Oats bet on the wrong horse. If he doesn't pull the ripcord now - when will he?
With Oats we have the majority of votes at the next AGM. Then Gilles is history! - and Proph... is too!
It is a shame that someone stands here and tells something about biotech index or other stocks that have also taken heavy losses.
We are shareholders of Ceapro and we don't need anyone to keep whitewashing the bad story.
The truth is: our investment is a catastrophe.
Gilles is one tall tale - he has to go!!!